These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 768802

  • 1. Clonidine and the anti-parkinsonian response to L-DOPA or piribedil.
    Shoulson I, Chase TN.
    Neuropharmacology; 1976 Jan; 15(1):25-7. PubMed ID: 768802
    [No Abstract] [Full Text] [Related]

  • 2. Indications of piribedil in L-DOPA-treated parkinsonian patients: physiopathologic implications.
    Rondot P, Bathien N, Dumas JL.
    Adv Neurol; 1975 Jan; 9():373-81. PubMed ID: 1096574
    [No Abstract] [Full Text] [Related]

  • 3. Dopaminergic agonist effects on Parkinsonian clinical features and brain monamine metabolism.
    Rinne UK, Sonninen V, Marttila R.
    Adv Neurol; 1975 Jan; 9():383-92. PubMed ID: 1096575
    [Abstract] [Full Text] [Related]

  • 4. Piribedil (ET 495) in the treatment of Parkinson's disease combined with amantadine or levodopa.
    Callaghan N, Fitzpatrick E, O'Mahony JB.
    Acta Neurol Scand; 1975 Sep; 52(3):179-86. PubMed ID: 1098359
    [Abstract] [Full Text] [Related]

  • 5. [Piribedil in the treatment of Parkinson disease (author's transl)].
    Nardini M, Sciannandrone R, Fieschi C, De Simone G.
    Riv Patol Nerv Ment; 1975 Sep; 96(2):103-10. PubMed ID: 778998
    [Abstract] [Full Text] [Related]

  • 6. [Piribedil, dopaminergic agonist. Prolonged clinical and electrophysiological study in 60 parkinsonian patients (author's transl)].
    Truelle JL, Chanelet J, Bastard J, Six P, Emile J.
    Nouv Presse Med; 1977 Oct 08; 6(33):2987-90. PubMed ID: 22844
    [Abstract] [Full Text] [Related]

  • 7. Caffeine and the antiparkinsonian response to levodopa or piribedil.
    Shoulson I, Chase T.
    Neurology; 1975 Aug 08; 25(8):722-4. PubMed ID: 125389
    [Abstract] [Full Text] [Related]

  • 8. [Long-term clinical and electrophysiological study of a new dopaminergic agonist in 54 patients with parkinsonism].
    Truelle JL, Chanelet J, Bastard J, Six P, Emile J.
    Sem Hop Ther; 1977 Nov 08; 53(9):453-6. PubMed ID: 341320
    [No Abstract] [Full Text] [Related]

  • 9. Piribedil--an oral dopamine agonist for treatment of Parkinson's disease.
    Sweet RD, Wasterlain C, McDowell FH.
    Trans Am Neurol Assoc; 1974 Nov 08; 99():258-60. PubMed ID: 4463553
    [No Abstract] [Full Text] [Related]

  • 10. Piribedil: its synergistic effect in multidrug regimens for parkinsonism.
    Feigenson JS, Sweet RD, McDowell FH.
    Neurology; 1976 May 08; 26(5):430-3. PubMed ID: 944394
    [Abstract] [Full Text] [Related]

  • 11. A comparison of piribedil, procyclidine and placebo in the control of phenothiazine-induced parkinsonism.
    Mindham RH, Lamb P, Bradley R.
    Br J Psychiatry; 1977 Jun 08; 130():581-5. PubMed ID: 326325
    [Abstract] [Full Text] [Related]

  • 12. Piribedil in Parkinson's syndrome: a clinical study.
    Engel J, Granerus AK, Svanborg A.
    Eur J Clin Pharmacol; 1975 Apr 04; 8(3-4):223-6. PubMed ID: 183960
    [Abstract] [Full Text] [Related]

  • 13. Piribedil as an adjunct to levodopa in advanced Parkinson's disease: the Asian experience.
    Evidente VG, Esteban RP, Domingo FM, Carbajal LO, Parazo MA.
    Parkinsonism Relat Disord; 2003 Dec 04; 10(2):117-21. PubMed ID: 14644004
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Studies on piribedil in Parkinsonism.
    Lieberman AN, Shopsin B, Brun YL, Boal D, Zolfaghari M.
    Adv Neurol; 1975 Dec 04; 9():399-407. PubMed ID: 125032
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.